Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Mouth Neoplasms × Aminolevulinic Acid × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 4 Glioma 3 Brain Neoplasms 3 Neoplasms, Basal Cell 1 Mouth Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Leukoplakia 1 Erythroplasia 1 Colorectal Neoplasms 1 Carcinoma, Basal Cell 1

Interventions

Cisplatin 4 Radiotherapy 2 Paclitaxel 2 tozuleristide 1 pembrolizumab 1 niraparib 1 dostarlimab 1 dacomitinib 1 advexin 1 Taxes 1 Sirolimus 1 Photochemotherapy 1 Pemetrexed 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Chemoprevention 1 Celecoxib 1 Calcitriol 1 Aminolevulinic Acid 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03638622 2021-02-21

UH3-India

Massachusetts General Hospital

Phase 1/2 Completed

30 enrolled 4 charts

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡